Biohaven's troriluzole candidate for spinocerebellar ataxia (SCA) has been turned down by the FDA, causing shares in the company to lose more than 40% of their value in pre-market trading. The news is ...
After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU. Skyclarys ...
Severe neurodegeneration is one of several clinical features of ataxia-telangiectasia (AT), yet control of CNS symptoms in patients with AT has received little attention. Buoni et al. have presented a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results